Actively Recruiting
Study of the Effect of Ginger Capsules on Markers of Inflammation, Oxidative Stress, and Endothelial Damage
Led by Ana Mª Garcia Munoz · Updated on 2026-03-09
50
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of daily ginger capsule consumption on inflammation, oxidative stress, and endothelial damage in adults with excess body fat. This randomized, double-blind, placebo-controlled trial aims to understand how ginger impacts markers related to cardiometabolic risk factors over a 60-day period. Participants will be randomly assigned to one of two groups: one group will take two ginger capsules daily, each containing 500 mg of ginger extract, and the other will take two placebo capsules without any active ingredients. Both groups will follow their assigned regimen for 60 days, maintaining the double-blind design to ensure unbiased results. During the study, participants will undergo assessments on day 1 and day 60, including blood tests measuring inflammatory markers like interleukin-1 beta and interleukin-6, oxidative stress markers such as homocysteine, and other cardiovascular risk factors like fibrinogen levels and the atherogenic index. Additional measures include cholesterol levels, blood sugar, body weight, body composition, and blood pressure. The study carefully monitors these parameters to evaluate changes associated with ginger intake compared to placebo.
CONDITIONS
Brief Title
Effect of Ginger Capsules on Inflammation, Oxidative Stress, and Endothelial Function
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female participants.
- Age between 23 and 65 years.
- Body mass index (BMI) greater than 27.5 kg/m².
- Absence of diagnosed chronic diseases.
- Not receiving pharmacological treatment or dietary supplementation regularly.
- Ability to understand study procedures and willingness to comply with requirements.
You will not qualify if you...
- Presence of acute or chronic diseases not specified in the inclusion criteria.
- Ongoing chronic pharmacological treatment or active use of dietary supplements.
- Major surgery within the previous three months.
- Current smokers or recent former smokers (less than six months since stopping).
- History of clinically relevant food allergies or eating disorders.
- Concurrent participation in another clinical trial or research study.
- Pregnancy or breastfeeding.
- Following an active weight-loss diet.
- Investigator's judgment of unsuitability for study participation.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 60 days
Participants consume ginger capsules or placebo capsules daily for 60 days according to their assigned group.
1 baseline visit and 1 follow-up visit
Trial Site Locations
Total: 1 location
1
Universidad Católica San Antonio de Murcia
Murcia, Murcia, Spain, 30107
Actively Recruiting
Research Team
A
Ana Mª García Muñoz
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here